January 09, 2014
In its first round of proof-of-concept funding, Drexel Ventures — the University’s new technology accelerator and transfer enterprise — is supporting research that could lead to improved solar cells, new drug therapy for treatment of Parkinson’s Disease, safer chemicals for oil extraction and smarter software system monitoring.
